Drawing for JAZOXI

USPTO serial 77006737

JAZOXI

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
LORENZO, GEORGE M
Law office
TTAB

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 604: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with JAZOXI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Bruce W. Longbottom

BRUCE W. LONGBOTTOM ELI LILLY AND COMPANYLILLY CORPORATE CTRINDIANAPOLIS, IN 46285-0001UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorders, anxiety, bone and skeletal diseases and disorders, blood diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, diabetes, diabetic neuropathy, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, liver diseases and disorders, kidney diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, obesity, ophthalmologic conditions and diseases, pain, peripheral nervous system diseases and disorders, reproductive system diseases and disorders, sexual dysfunction, urological disorders, dyslipidemia, sleep disorders, migraines, metabolic diseases and disorders; pharmaceutical preparations for the prevention of diabetes; antipsychotic agents; and antidepressantsABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 8, 2007MAB4ABANDONMENT NOTICE MAILED - INTER PARTES DECISION—
Aug 8, 2007ABN4ABANDONMENT - AFTER INTER PARTES DECISION—
Aug 8, 2007OP.SOPPOSITION SUSTAINED NO. 999999—
Apr 25, 2007OP.IOPPOSITION INSTITUTED NO. 999999—
Feb 6, 2007ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Jan 9, 2007PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 20, 2006NPUBNOTICE OF PUBLICATION—
Nov 15, 2006PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Nov 9, 2006ALIEASSIGNED TO LIE—
Nov 3, 2006CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 2, 2006DOCKASSIGNED TO EXAMINER—
Oct 2, 2006NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance